陈云红, 孙常晟, 芮耀诚. 5-取代-4-甲基-1,3-二氢-2H-咪唑-2-酮类化合物的合成及其强心作用J. 药学学报, 1988, 23(1): 21-27.
引用本文: 陈云红, 孙常晟, 芮耀诚. 5-取代-4-甲基-1,3-二氢-2H-咪唑-2-酮类化合物的合成及其强心作用J. 药学学报, 1988, 23(1): 21-27.
YH Chen, CS Sun, , YC Rui. SYNTHESIS AND CARDIOTONIC ACTIVITIES OF 5-SUBSTITUTED-4-METHYL-1, 3-DIHYDRO-2H-IMIDAZOL-2-ONESJ. Acta Pharmaceutica Sinica, 1988, 23(1): 21-27.
Citation: YH Chen, CS Sun, , YC Rui. SYNTHESIS AND CARDIOTONIC ACTIVITIES OF 5-SUBSTITUTED-4-METHYL-1, 3-DIHYDRO-2H-IMIDAZOL-2-ONESJ. Acta Pharmaceutica Sinica, 1988, 23(1): 21-27.

5-取代-4-甲基-1,3-二氢-2H-咪唑-2-酮类化合物的合成及其强心作用

SYNTHESIS AND CARDIOTONIC ACTIVITIES OF 5-SUBSTITUTED-4-METHYL-1, 3-DIHYDRO-2H-IMIDAZOL-2-ONES

  • 摘要: 本文设计并合成了5-取代-4-甲基-1,3-二氢-2 H-咪唑-2-酮类化合物23个,其中19个尚未见报道。中间体5-(4-溴甲基苯甲酰基)-4-甲基-1,3-二氢-2H-咪唑-2-酮(Ⅴ)为一新化合物。在关键中间体4-甲基-1,3-二氢-2H-咪唑-2-酮(Ⅳ)的合成中,设计了由β-羟基丙胺一步氧化直接合成氨基丙酮的新方法。药理初筛表明:Ⅱ1,Ⅱ2,Ⅱ4,Ⅲ4,Ⅲ6,Ⅲ7,Ⅲ8和RMI 82,249(1)具有不同程度的正性肌力作用,其中4个未知化合物Ⅱ1,Ⅱ2,Ⅱ4和Ⅲ4的最大效应高于已知对照物(1)。Ⅱ4既增加心肌收缩力,又减慢心率,值得进一步研究。

     

    Abstract: Twenty-three derivatives of 5-substituted-4-methyl-1,3-dihydro-2 H-imidazol-2-one were designed and synthesized for searching of more potent and less toxic cardiotonic agents. The key intermediate, 4-methyl-1,3-dihydro-2H-imidazol-2-one(Ⅳ), was prepared by a method of one-step oxidation of β-hydroxy propylaminc, a new synthesis of aminoacetone.Preliminary pharmacologic tests on isolated male guinca pig atria showed that eight of the synthetic compounds (Ⅱ1, Ⅱ2, Ⅱ4, Ⅲ4, Ⅲ6, Ⅲ7, Ⅲ8 and 1) exhibited significant positive inotropic activities. The maximum inotropic effects of four of them (Ⅱ1, Ⅱ2, Ⅱ4 and Ⅲ4) were higher than those of the known cardiotonic agent, RMI 82,249(1). It is interesting that Ⅱ4 showed both positive inotropic and negative chronotropic effects significantly.

     

/

返回文章
返回